XML 46 R8.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating activities:    
Net loss $ (204,653) $ (7,746)
Adjustments to reconcile net loss to cash provided by operating activities:    
Amortization of investment premiums 20,691 18,253
Amortization of equity-based awards 835 1,109
Amortization of unrealized gain on de-designated hedges (103) (3,020)
Loss on sale of mortgage investments 67,820  
Loss on derivative instruments (net) 156,747 26,237
Other depreciation and amortization 29 27
Net change in receivables, other assets, accounts payable and accrued expenses (1,872) 12,635
Net cash provided by operating activities 39,494 47,495
Investing activities:    
Purchases of residential mortgage investments (814,547) (994,371)
Proceeds from sales of residential mortgage investments 2,540,426  
Interest receivable acquired with the purchase of residential mortgage investments (1,495) (2,190)
Principal collections on residential mortgage investments, including changes in mortgage securities principal remittance receivable 902,873 768,168
Redemption of lending counterparty investments   5,000
Net cash provided by (used in) investing activities 2,627,257 (223,393)
Financing activities:    
Proceeds from repurchase arrangements and similar borrowings 29,271,292 31,034,056
Principal payments on repurchase arrangements and similar borrowings (31,167,283) (30,790,967)
Increase in cash collateral receivable from derivative counterparties (30,452) (26,394)
Increase in cash collateral receivable from secured borrowing counterparties (359,168)  
Net payments on derivative settlements (150,760) (56,731)
Issuance of common stock 12,882  
Other capital stock transactions (107) (106)
Dividends paid (19,104) (11,816)
Net cash (used in) provided by financing activities (2,442,700) 148,042
Net change in cash and cash equivalents 224,051 (27,856)
Cash and cash equivalents at beginning of period 105,397 60,289
Cash and cash equivalents at end of period $ 329,448 $ 32,433